From the molecule to the vessel wall: understanding the science, technology and evidence behind MagicTouch
Drug-coated balloon technology brings together a simple idea with a complex scientific process: delivering a drug to the vessel wall where it is needed.
The technology involves more than the balloon itself. It brings together the drug, the delivery platform, the vessel wall and the clinical evidence that helps us understand its performance. This article takes a closer look at these elements, beginning with one of the key molecules in the MagicTouch platform: sirolimus.
Why Sirolimus?
Understanding the molecule behind the technology
Sirolimus belongs to the limus family of drugs. It is a cytostatic, anti-proliferative drug with a wide therapeutic window.
But selecting the drug is only the beginning. In drug-coated balloon technology, the drug needs to be delivered from the balloon to the vessel wall during the procedure. How that transfer takes place is therefore an important part of the technology.
This shifts the focus from simply asking “Which drug?” to a broader question: “How can the drug be delivered to where it is needed?”
From the Balloon to the Vessel Wall
Where drug and delivery technology come together
A drug-coated balloon is designed to provide local drug delivery during an intervention. The balloon acts as the temporary platform, with the objective of transferring the drug to the vessel wall.
MagicTouch uses Nanolute technology to carry sirolimus to the vessel wall and help it stay where it is needed.
This makes the delivery process an important part of understanding drug-coated balloon technology. It is not simply about the presence of a drug on a balloon; it is about the interaction between the drug, the delivery technology and the vessel wall.
That interaction lies at the heart of precision drug delivery.
Why Does Delivery Matter?
The science goes beyond the drug itself
When considering a drug-coated balloon, it is easy to focus on the active drug. However, the way that drug reaches the vessel wall is equally important.
The journey can be understood through four connected elements:
The Drug → The Delivery Technology → The Vessel Wall → The Clinical Evidence
Each element contributes to the broader understanding of the technology from the properties of the molecule and its delivery to the evidence generated through clinical research.
From Science to Evidence
Building clinical experience around the technology
Scientific development is ultimately supported by evidence. The MagicTouch platform has a growing evidence base, including 35+ clinical trials spanning randomized and real-world studies.
Studies including EASTBOURNE, SIRONA, SIRPAD and IMPRESSION form part of this expanding evidence story across different clinical categories.
The platform’s reported global footprint includes 70+ countries, 350K+ patients treated, 125+ patents, 20K+ patients involved in studies and 50+ publications.
Together, these elements represent a journey from the science of the molecule and its delivery to clinical research and experience.
Exploring Multiple Clinical Areas
One platform, multiple areas of development
The development of MagicTouch extends across multiple disease areas. The platform is represented across coronary artery disease, peripheral artery disease, arteriovenous fistula and graft, erectile dysfunction, carotid artery disease, intracranial atherosclerosis, urethral stricture and renal disease, with certain applications identified as under development.
Exploring the technology across different areas highlights the broader potential of a drug-delivery platform and its application to different clinical needs.
Following the Journey
From molecule to method to evidence
The story of a drug-coated balloon does not begin and end with the device. It begins with the molecule, continues through the technology used to deliver it, and ultimately leads to the clinical evidence generated through research.
For sirolimus-coated balloon technology, following this journey helps bring these different elements together and provides a clearer understanding of why the delivery process matters.
From the drug to the vessel wall, every step is part of the science.
